Blood vessels grown in live animals

November 19, 2001

ARLINGTON, Va., -- Biomedical engineers at the University of Michigan have grown a healthy network of blood vessels in live animals using implants that deliver critical growth enzymes sequentially as in nature.

"To grow a replacement tissue cell by cell, you need a combination of growth factors delivered in the right sequence at the proper time and in the right place," said David Mooney, Ph.D., professor of biologic and materials science at Michigan and a Whitaker Investigator. "Just injecting a large amount of it with a needle doesn't work."

The experiments, reported in the current issue of the journal Nature Biotechnology, represent an early step toward growing new tissues in the human body, since all living tissues require blood circulation.

Possible medical applications include alternatives to heart bypass surgery, faster wound healing, and treatments for vascular disease in diabetics. The implants might also be used to deliver other drugs or therapeutic agents.

At least two enzymes or growth factors are needed for new blood vessels: vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF). VEGF initiates vessel growth, while PDGF promotes maturation by giving the vessels a strong interior lining. The continued presence of VEGF also prevents vessels from regressing as they mature.

The research group attempted to duplicate the sequential release of the growth factors by mixing them with a polymer in different ways and then melding everything into a porus scaffold to be implanted. As the scaffold dissolved, it released the growth factors one before the other with some overlap. The scaffold is designed to disappear altogether over time.

The Michigan group mixed VEGF with particles of the polymer for immediate and sustained release and encapsulated PDGF in polymer microspheres for slow release. The release rate and amount were controlled by the thickness and number of microspheres. Both the polymer-particle mixture and the microspheres were combined to make the scaffold.

The researchers conducted three experiments. First they confirmed the release rates of both growth factors in laboratory dishes, then implanted four types of scaffolds in healthy rats. One type contained VEGF alone, another PDGF, the third had both, the fourth neither. The rats were examined after two weeks and again in a month. Only rats that received both growth factors had grown new, mature blood vessels after four weeks.

In the third study, the researchers attempted to treat vascular disease in 16 diabetic mice using the same combination of four scaffold types. Again, only the dual-release scaffolds stimulated a mature vascular network.

Peter Carmeliet and Edward M. Conway of the University of Leuven in Belgium commented on the research in the same issue of Nature Biotechnology. They compared the Michigan approach to contemporary efforts to stimulate blood vessel formation using other methods, such as gene transfer, noting that none of the othermethods mimicked nature's timed-release delivery of multiple growth factors.

"Obviously, future work is needed to demonstrate the value of this system for [therapy]," they wrote. "Nonetheless, the exciting findings ... underscore the importance of paying attention to not only the type of angiogenic growth factor employed for therapeutic angiogenesis, but also how and when they should be delivered."
Mooney's group included postdoctoral student Thomas P. Richardson and graduate students Martin C. Peters, a Whitaker Fellow, and Alessandra B. Emmett. Mooney received a Biomedical Engineering Research Grant from the foundation in 1995 for tissue engineering research. Peters received a Whitaker Foundation Graduate Fellowship in 1996.

Whitaker Foundation

Related Blood Vessels Articles from Brightsurf:

Biofriendly protocells pump up blood vessels
In a new study published today in Nature Chemistry, Professor Stephen Mann and Dr Mei Li from Bristol's School of Chemistry, together with Associate Professor Jianbo Liu and colleagues at Hunan University and Central South University in China, prepared synthetic protocells coated in red blood cell fragments for use as nitric oxide generating bio-bots within blood vessels.

Specific and rapid expansion of blood vessels
Upon a heart infarct or stroke, rapid restoration of blood flow, and oxygen delivery to the hypo perfused regions is of eminent importance to prevent further damage to heart or brain.

Flexible and biodegradable electronic blood vessels
Researchers in China and Switzerland have developed electronic blood vessels that can be actively tuned to address subtle changes in the body after implantation.

Lumpy proteins stiffen blood vessels of the brain
Deposits of a protein called ''Medin'', which manifest in virtually all older adults, reduce the elasticity of blood vessels during aging and hence may be a risk factor for vascular dementia.

Cancer cells take over blood vessels to spread
In laboratory studies, Johns Hopkins Kimmel Cancer Center and Johns Hopkins University researchers observed a key step in how cancer cells may spread from a primary tumor to a distant site within the body, a process known as metastasis.

Novel function of platelets in tumor blood vessels found
Scientists at Uppsala University have discovered a hitherto unknown function of blood platelets in cancer.

Blood vessels can make you fat, and yet fit
IBS scientists have reported Angiopoietin-2 (Angpt2) as a key driver that inhibits the accumulation of potbellies by enabling the proper transport of fatty acid into general circulation in blood vessels, thus preventing insulin resistance.

Brothers in arms: The brain and its blood vessels
The brain and its surrounding blood vessels exist in a close relationship.

Feeling the pressure: How blood vessels sense their environment
Researchers from the University of Tsukuba discovered that Thbs1 is a key extracellular mediator of mechanotransduction upon mechanical stress.

Human textiles to repair blood vessels
As the leading cause of mortality worldwide, cardiovascular diseases claim over 17 million lives each year, according to World Health Organization estimates.

Read More: Blood Vessels News and Blood Vessels Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to